Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: Arjun Chal (Terminalia arjuna): Fine Powder of Arjun Chal (3gm) will be given in capsule form daily in 2 divided doses. each capsule will contain 750mg of the Chal Arjun for 6 weeks. Pa
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patient aged 20 to 70 years of either sex 2)Confirmed diagnosis of Dyslipidemia (as per NCEP ATP III guidelines) Total cholesterol 200-250 mg per dL, or LDL-C 130-189 mg per dL, or HDL-C less than 40 mg per dL and more than 60 mg per dL, or Triglycerides 150-499 mg per dL 3)Subjects on statins 4)Controlled Diabetes and Hypertension
Exclusion criteria
Exclusion criteria: 1)Pregnant and lactating women 2)Secondary causes of hyperlipidemia (example Hypothyroidism, nephrotic syndrome, uncontrolled diabetes) 3)History of Cardiovascular events (recent myocardial infarction, congenital heart disease or rheumatic heart disease, stroke, or unstable angina within the past 6 month) 4)Hepatic or renal failure or disease 5)Uncontrolled hypertension (SBP more than 160mmHg or DBP more than 100 mmHg) despite treatment 6)Poorly controlled diabetes (FBS more than 130mg per dL) 7)A medical condition that in the investigator opinion would interfere with treatment, safety or adherence to the protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in lipid profile (Serum Cholesterol, Serum triglycerides and LDL, VLDL, HDL).Timepoint: At baseline and after 6 weeks of clinical trial | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in subjective parameters (Dyspnea, Fatigue or Weakness, Chest pain, Palpitation) Reduction in Systolic and Diastolic blood pressure.Timepoint: For 6 weeks (0,14th,28th,42nd) | — |
Countries
India
Contacts
Public ContactDr Muzafar Din Ahmad Bhat
National Institute of Unani Medicine Kottigepalya Magadi Main Road Bangalore Karnataka
Outcome results
None listed